extended release naltrexone
extended release naltrexone is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery
Extended Release Naltrexone for Opioid-Dependent Youth
Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone
Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
Clinical Trials (6)
Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery
Extended Release Naltrexone for Opioid-Dependent Youth
Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone
Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6